BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12518864)

  • 1. Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer.
    Ho WL; Chang JW; Tseng RC; Chen JT; Chen CY; Jou YS; Wang YC
    Cancer Detect Prev; 2002; 26(5):343-9. PubMed ID: 12518864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer.
    Sanz-Ortega J; Roig F; Al-Mousa MM; Saez MC; Muñoz A; Sanz-Esponera J; Callol L
    Histol Histopathol; 2007 May; 22(5):541-5. PubMed ID: 17330809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer.
    Tseng RC; Chang JW; Hsien FJ; Chang YH; Hsiao CF; Chen JT; Chen CY; Jou YS; Wang YC
    Int J Cancer; 2005 Nov; 117(2):241-7. PubMed ID: 15900585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
    Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
    Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of tumor suppressor genes in Chinese non-small cell lung cancer.
    An Q; Liu Y; Gao Y; Huang J; Fong X; Liu L; Zhang D; Zhang J; Cheng S
    Cancer Lett; 2002 Oct; 184(2):189-95. PubMed ID: 12127691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
    Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
    Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
    Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
    Geradts J; Fong KM; Zimmerman PV; Minna JD
    Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of tumor suppressor gene deletion between squamous cell carcinoma and adenocarcinoma lung cancer in Chinese].
    An Q; Liu Y; Huang J
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):470-2. PubMed ID: 11859712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
    Yoshino I; Osoegawa A; Yohena T; Kameyama T; Oki E; Oda S; Maehara Y
    Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.